A Phase 3 Clinical Trial to Compare RBS-001 to Eylea® in Subjects With Neovascular Age-Related Macular Degeneration
A Phase 3 Clinical Trial to Compare RBS-001 to Eylea® in Subjects With Neovascular Age-Related Macular Degeneration
Not yet recruiting · NCT06470373 · Registry updated 2025-04-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 3 Clinical Trial to Compare RBS-001 to Eylea® in Subjects With Neovascular Age-Related Macular Degeneration | Neovascular Age-related Macular Degeneration (nAMD) | Not yet recruiting | Phase 3 | 2025-04-06 | NCT06470373 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Rophibio, Inc. | 1 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Associated Retina Consultants - Gilbert | Phoenix | United States | 1 |
| Associated Retina Consultants - Phoenix | Phoenix | United States | 1 |
| Charles Retina Institute | Germantown | United States | 14 |
| Erie Retina Research | Erie | United States | 18 |
| Retina Partners of Northwest Arkansas, PLLC | Springdale | United States | 4 |
| Retina Research Institute of Texas | Abilene | United States | 17 |
| Strategic Clinical Research Group, LLC | Willow Park | United States | 10 |